40 results
6-K
EX-99.2
AMYT
Amryt Pharma Plc
12 Apr 23
Current report (foreign)
5:28pm
) in the event of litigation or other dispute resolution, the Rights Agent may engage and consult with regulatory experts, drug development experts
6-K
EX-99.1
AMYT
Amryt Pharma Plc
3 Apr 23
High Court of Justice of England and Wales Sanctions Scheme of Arrangement
9:00am
of the acquisition; significant Transaction costs and/or unknown or inestimable liabilities; the risk of shareholder litigation in connection with the proposed
6-K
EX-99.1
kyn2e57l4dfm
25 Feb 22
Current report (foreign)
4:05pm
424B3
doafstjy
1 Jul 21
Prospectus supplement
5:20pm
F-4/A
sfslyv5
29 Jun 21
Registration of securities (foreign) (amended)
9:29am
425
388ugn
15 Jun 21
Business combination disclosure
4:28pm
F-4
v9ymxo8
15 Jun 21
Registration of securities (foreign)
12:00am
424B3
27zpgag 084s
2 Jun 21
Prospectus supplement
10:10am
424B3
s6f0y 57skso8c5
2 Jun 21
Prospectus supplement
10:09am
425
j07yap ht9
5 May 21
Business combination disclosure
5:27pm
425
p5sj oqvrfkfhyk
5 May 21
Business combination disclosure
5:24pm
6-K
zxe an1q7exluh5d
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
EX-99.1
osa4 cbl6
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
EX-99.5
05mqkz3g h0se8
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
EX-99.1
fws73tw
5 May 21
Amryt Pharma to Acquire Chiasma, Inc. to Further Strengthen Global Leadership in Rare and Orphan Diseases
8:45am
20-F
nlofmswn8nb1b1
30 Apr 21
Annual report (foreign)
12:53pm
424B4
y5s7tnp tg5
14 Jan 21
Prospectus supplement with pricing info
9:30am